Patents by Inventor Francesca Demichelis

Francesca Demichelis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7981609
    Abstract: Described are methods for identifying single nucleotide polymorphism (SNPs) that are useful for analyzing genetic samples, and for using said SNPs to determine genetic identity of samples.
    Type: Grant
    Filed: June 8, 2007
    Date of Patent: July 19, 2011
    Assignees: The Brigham and Women's Hospital, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Mark A. Rubin, Francesca Demichelis, Levi A. Garraway, William R. Sellers
  • Publication number: 20110034677
    Abstract: Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
    Type: Application
    Filed: December 30, 2009
    Publication date: February 10, 2011
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: Scott Tomlins, Daniel Rhodes, Arul Chinnaiyan, Rohit Mehra, Mark A. Rubin, Xiao-Wei Sun, Sven Perner, Charles Lee, Francesca Demichelis
  • Patent number: 7803552
    Abstract: The present invention relates to the identification and use of gene expression profiles with clinical relevance to prostate cancer. In particular, the invention provides the identity of genes whose expression, at the transcriptional and protein levels, is correlated with prostate cancer progression. Methods and kits are described for using these gene expression profiles in the study and/or diagnosis of prostate cancer diseases, in the prediction of prostate cancer progression, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that target these genes or their protein products, in particular for the development of therapeutics for modulating prostate cancer progression.
    Type: Grant
    Filed: October 27, 2009
    Date of Patent: September 28, 2010
    Assignee: The Brigham & Women's Hospital, Inc.
    Inventors: Mark A. Rubin, Francesca DeMichelis
  • Publication number: 20100137164
    Abstract: The present invention relates to the identification and use of gene expression profiles with clinical relevance to prostate cancer. In particular, the invention provides the identity of genes whose expression, at the transcriptional and protein levels, is correlated with prostate cancer progression. Methods and kits are described for using these gene expression profiles in the study and/or diagnosis of prostate cancer diseases, in the prediction of prostate cancer progression, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that target these genes or their protein products, in particular for the development of therapeutics for modulating prostate cancer progression.
    Type: Application
    Filed: October 27, 2009
    Publication date: June 3, 2010
    Applicant: The Brigham and Women's Hospital, Inc.
    Inventors: Mark A. Rubin, Francesca Demichelis
  • Patent number: 7718369
    Abstract: Recurrent gene fusions of androgen regulated genes and ETS family member genes in prostate cancer are described. Compositions and methods having utility in prostate cancer diagnosis, research, and therapy are also provided.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: May 18, 2010
    Assignees: The Regents of the University of Michigan, The Brigham and Women's Hospital, Inc.
    Inventors: Scott Tomlins, Daniel Rhodes, Arul Chinnaiyan, Rohit Mehra, Mark A. Rubin, Xiao-Wei Sun, Sven Perner, Charles Lee, Francesca Demichelis
  • Patent number: 7666595
    Abstract: The present invention relates to the identification and use of gene expression profiles with clinical relevance to prostate cancer. In particular, the invention provides the identity of genes whose expression, at the transcriptional and protein levels, is correlated with prostate cancer progression. Methods and kits are described for using these gene expression profiles in the study and/or diagnosis of prostate cancer diseases, in the prediction of prostate cancer progression, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that target these genes or their protein products, in particular for the development of therapeutics for modulating prostate cancer progression.
    Type: Grant
    Filed: February 24, 2006
    Date of Patent: February 23, 2010
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Mark A. Rubin, Francesca Demichelis
  • Publication number: 20090004652
    Abstract: Described are methods for identifying single nucleotide polymorphism (SNPs) that are useful for analyzing genetic samples, and for using said SNPs to determine genetic identity of samples.
    Type: Application
    Filed: June 8, 2007
    Publication date: January 1, 2009
    Inventors: Mark A. Rubin, Francesca Demichelis, Levi A. Garraway, William R. Sellers
  • Publication number: 20060234259
    Abstract: The present invention relates to the identification and use of gene expression profiles with clinical relevance to prostate cancer. In particular, the invention provides the identity of genes whose expression, at the transcriptional and protein levels, is correlated with prostate cancer progression. Methods and kits are described for using these gene expression profiles in the study and/or diagnosis of prostate cancer diseases, in the prediction of prostate cancer progression, and in the selection and/or monitoring of treatment regimens. The invention also relates to the screening of drugs that target these genes or their protein products, in particular for the development of therapeutics for modulating prostate cancer progression.
    Type: Application
    Filed: February 24, 2006
    Publication date: October 19, 2006
    Inventors: Mark Rubin, Francesca Demichelis
  • Patent number: 4331829
    Abstract: A thermophotovoltaic converter of the type comprising a concentrating optical system and a transducer for solar radiation provided with at least one lens and with at least one photovoltaic cell is described.The principal feature of this converter is that the aforementioned transducer comprises at least a radiator having an irradiating surface substantially facing the sensitive surface of the photovoltaic cell and a selective filter disposed between the photovoltaic cell and the aforementioned radiator.
    Type: Grant
    Filed: October 3, 1980
    Date of Patent: May 25, 1982
    Assignees: Centro Ricerche Fiat S.p.A., Politecnico di Torino
    Inventors: Mario Palazzetti, Angioletta Boero, Francesca Demichelis, Enrica Minetti-Mezetti, Giancarlo Ferrari
  • Patent number: 4287881
    Abstract: A solar energy absorber comprises a thermally-insulated duct housing a plurality of longitudinally-extending absorbing plates and having a slit located at the focal axis of an elongate, optical focusing system. The plates are parallel to the plane of symmetry of the optical system and are spaced apart such that focused energy incident through the slit falls upon an entire surface of each plate, any reflected energy being returned to the plates by a plane mirror located on the opposite side of the plates from the slit and by internal reflecting surfaces of the duct such that substantially all the energy is absorbed: this energy is given up to an air flow through the duct, in use.
    Type: Grant
    Filed: February 7, 1980
    Date of Patent: September 8, 1981
    Assignee: Centro Ricerche Fiat S.p.A.
    Inventors: Mario Palazzetti, Angioletta Boero, Francesca Demichelis, Enrica Minetti-Mezzetti